TABLE 1.
Memory disorders clinic demographic and clinical features at initial evaluation
| Characteristics | Data |
|---|---|
| Age in years, mean ± SD | 73.78 ± 8.93 |
| Male gender, n (%) | 549 (97.2%) |
| Years of education, mean ± SD | 13.80 ± 2.63 |
| Duration of symptoms, years | Median: 2 (IQR: 1‐5) |
| MoCA initial visit, mean ± SD | 20.02 ± 4.74 |
| Family history of dementia n (%) | 191 (35.9%) |
| Suspected cognitive syndrome (n = 550), n (%) | |
| Unimpaired | 10 (1.8%) |
| Subjective cognitive decline | 32 (5.8%) |
| Mild cognitive impairment | 308 (56.0%) |
| Dementia | 200 (36.4%) |
| Suspected primary diagnosis (n = 435), n (%) | |
| Alzheimer's disease | 219 (50.3%) |
| Vascular | 39 (9.0%) |
| Lewy body diseases | 30 (6.9%) |
| Psychiatric disorders | 28 (6.4%) |
| BvFTD | 14 (3.2%) |
| Primary progressive aphasias | 7 (1.6%) |
| Chronic traumatic encephalopathy | 10 (2.3%) |
| Parkinson‐plus syndromes | 10 (2.3%) |
| Other | 55 (12.6%) |
| Unclear | 23 (5.3%) |
| Amyloid PET completed | 197 (34.9%) |
| Indication, n (%) | |
| Mild cognitive impairment | 93 (47.2%) |
| Dementia with atypical clinical | 75 (38.1%) |
| course or etiologically mixed | |
| Early onset dementia | 25 (12.7%) |
| Not fulfilling AUC | 4 (2.0%) |
n = 565.
Values represent number (percentage) and means with standard deviation.
IQR= interquartile range; MoCA= Montreal Cognitive Assessment, AUC= appropriate use criteria; BvFTD = behavioral variant frontotemporal dementia